Pharmacodynamics of colistin resistance in carbapenemase-producing Klebsiella pneumoniae: the double-edged sword of heteroresistance and adaptive resistance
Joseph Meletiadis(National and Kapodistrian University of Athens), S. Vourli, Marilena Tsala(National and Kapodistrian University of Athens), Paschalis Paranos(National and Kapodistrian University of Athens), Spyros Pournaras(National and Kapodistrian University of Athens)
Cited by 4
Related Papers
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Infections Caused by<i>Scedosporium</i>spp
|Clinical Microbiology Reviews|2008|757
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
|International Journal of Antimicrobial Agents|2012|502
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
|Clinical Microbiology and Infection|2011|441